Literature DB >> 30120561

Moyamoya angiopathy: early postoperative course within 3 months after STA-MCA-bypass surgery in Europe-a retrospective analysis of 64 procedures.

Markus Kraemer1,2, Jasmin Sassen3, Rusen Karakaya4, Jan Claudius Schwitalla4,5, Jonas Graf6, Philipp Albrecht6, Hans-Peter Hartung6, Rolf R Diehl4, Peter Berlit4, Rudolf Laumer3, Frank Diesner3.   

Abstract

BACKGROUND: Despite the consensus on the necessity of revascularizing surgery in Moyamoya angiopathy in Asia, the indication in Caucasian Moyamoya patients is discussed controversially.
OBJECTIVE: The safety of revascularizing surgery in Europe should be clarified.
METHODS: This study retrospectively analyzed the rate of complications as well as clinical symptoms within the first 3 months after bypass surgery between superficial temporal artery and middle cerebral artery (STA-MCA).
RESULTS: 64 direct bypass procedures in 45 patients (95.5% Caucasians) were analyzed. The magnetic resonance imaging at day 6 showed subdural hematoma in 60.3%. The mean diameter of these hematomas on magnetic resonance imaging was 5.1 mm (SD 3.4 mm) and increased in 25% at follow-up. No difference was found between those patients with early (day 1) or late (day 7) restarts of antiplatelet therapy. Magnetic resonance imaging at day 6 revealed hyperperfusion syndrome after six of 64 procedures (9.3%). Three of these six had clinical symptoms; two-thirds were transient within seconds. Magnetic resonance imaging depicted stroke after seven procedures (10.9%). Five of these seven patients had no new symptoms. Altogether, after ten procedures (15%), patients complained about clinical symptoms. These were all transient. No new transient ischemic attacks occurred during the 3 month follow-up and no new lesions were detected in magnetic resonance imaging. Only two patients underwent surgery for asymptomatic subdural hematoma. All other subdural hematomas resolved spontaneously.
CONCLUSION: Revasculating surgery is a safe procedure in Caucasian patients with Moyamoya angiopathy. The observed complications have a good prognosis.

Entities:  

Keywords:  Caucasians; Early postoperative course; Moyamoya angiopathy; Risks; Subdural hematoma

Mesh:

Substances:

Year:  2018        PMID: 30120561     DOI: 10.1007/s00415-018-8997-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  37 in total

1.  Chronic subdural hematoma following bypass surgery--report of three cases.

Authors:  T Andoh; N Sakai; H Yamada; H Yano; H Hirayama; Y Imao; K Deguchi
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-08       Impact factor: 1.742

2.  Universal Bypass for Treatment of Symptomatic Moyamoya Disease or Moyamoya Syndrome. Analysis of a Personal Case Series on Behalf of the Italian Moyamoya Association.

Authors:  Luigi A Lanterna; Carlo Brembilla; Paolo Gritti; Claudio Bernucci
Journal:  Acta Neurochir Suppl       Date:  2016

3.  EC-IC bypass for stroke: is there a future perspective?

Authors:  Daniel Hänggi; Hans-Jakob Steiger; Peter Vajkoczy
Journal:  Acta Neurochir (Wien)       Date:  2012-08-31       Impact factor: 2.216

4.  Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.

Authors:  Haruto Uchino; Satoshi Kuroda; Kenji Hirata; Tohru Shiga; Kiyohiro Houkin; Nagara Tamaki
Journal:  Stroke       Date:  2012-08-07       Impact factor: 7.914

5.  Effect of Surgery on the Long-Term Functional Outcome of Moyamoya Disease: A Meta-Analysis.

Authors:  Zhong Yao; Chao You
Journal:  Turk Neurosurg       Date:  2019       Impact factor: 1.003

Review 6.  Surgical management of Moyamoya disease and syndrome: Current concepts and personal experience.

Authors:  L Thines; G Petyt; P Aguettaz; M Bodenant; F-X Himpens; H Lenci; H Henon; C Gauthier; C Hossein-Foucher; C Cordonnier; J-P Lejeune
Journal:  Rev Neurol (Paris)       Date:  2014-12-30       Impact factor: 2.607

7.  Grading of moyamoya disease allows stratification for postoperative ischemia in bilateral revascularization surgery.

Authors:  M Czabanka; A Boschi; G Acker; P Peña-Tapia; G A Schubert; P Schmiedek; P Vajkoczy
Journal:  Acta Neurochir (Wien)       Date:  2016-08-30       Impact factor: 2.216

8.  [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].

Authors:  Ayumi Narisawa; Miki Fujimura; Hiroaki Shimizu; Teiji Tominaga
Journal:  No Shinkei Geka       Date:  2007-05

9.  Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.

Authors:  Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg
Journal:  J Neurosurg       Date:  2009-11       Impact factor: 5.115

Review 10.  Progress on Complications of Direct Bypass for Moyamoya Disease.

Authors:  Jinlu Yu; Lei Shi; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

View more
  3 in total

1.  High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.

Authors:  Jiaxi Li; Yahui Zhao; Meng Zhao; Penghui Cao; Xingju Liu; Hao Ren; Dong Zhang; Yan Zhang; Rong Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2019-06-15       Impact factor: 3.042

2.  Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.

Authors:  Rolf R Diehl; Markus Kraemer; Mosche Pompsch; Roland Veltkamp
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

3.  Clinical importance of the superficial temporal artery in neurovascular diseases: A PRISMA-compliant systematic review.

Authors:  Kun Hou; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2019-09-20       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.